Illumina (ILMN) Sinks as Roche Deal Put on Ice
Tweet
Share
E-mail
Get Alerts ILMN Hot Sheet
Join SI Premium – FREE
Illumina, Inc. (NASDAQ: ILMN) is under pressure early after Roche CEO Franz Humer said a deal is now "off the table" because the company is demanding too much.
Illumina reportedly asked Roche for $75/share and previously asked for $68/share.
This morning, Illumina announced the acquisition of Varinta Health for $450 million.
Shares of Illumina last traded at $48.48, down 11.5 percent.
Illumina reportedly asked Roche for $75/share and previously asked for $68/share.
This morning, Illumina announced the acquisition of Varinta Health for $450 million.
Shares of Illumina last traded at $48.48, down 11.5 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Illumina (ILMN) PT Raised to $225 at Baird
- Exclusive-US, China gear up for mid-September AI safety talks
- Fed's Hammack on LinkedIn: 'Right now, what I'm hearing is that it's time to act'
Create E-mail Alert Related Categories
Rumors, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
